top of page
Search


Singular Health Group – USD $1.3m U.S. Commercial Contract with PNS Signals First National-Scale Rollout – Healthcare Image Interoperability and Scalable SaaS Revenue
Samso is drawn to Singular Health because it is transitioning from proof-of-concept into contracted commercial deployment within the U.S. healthcare system. The Company is addressing a clearly defined inefficiency—medical imaging interoperability—through a regulatory-cleared, enterprise-ready platform with early validation from a large MSO partner.

Noel Ong
13 hours ago7 min read


Samso News: Vitrafy Life Sciences — IMV Strategic Commercial Agreement Marks a Commercial Validation Step - A Definite #SamsoDYOR and a strong consideration for position play.
Vitrafy Life Sciences Limited (ASX: VFY) released a market update on 15 January 2026 outlining a strategic commercial agreement with global animal reproduction leader IMV Technologies. The agreement positions Vitrafy’s cryopreservation technology within IMV’s global product and distribution platform, marking a material step in Vitrafy’s commercial execution strategy following Samso’s earlier IPO coverage of the Company.

Noel Ong
13 hours ago7 min read


Samso News: Pioneer Minerals — A Tungsten Story developing with a Capital Raise - A very Cheap Entry to the potential of Tungsten.
Samso is drawn to Pioneer Minerals because it offers direct leverage to U.S. critical minerals policy themes through a diversified portfolio spanning tungsten, antimony, uranium, and lithium, all within Tier-1 mining jurisdictions. The combination of historical production, recent high-grade surface results, and near-term drilling catalysts positions PMM as a company transitioning from early-stage consolidation into active value creation.

Noel Ong
2 days ago7 min read


Samso News: Cyprium Metals Limited — A$41m Equity Raising Advances Nifty Restart and Regional Copper Growth - Tracking the Transition to Near-Term Copper Production.
Cyprium Metals Limited (ASX: CYM) has announced a A$41 million equity capital raising to accelerate regional exploration and production growth initiatives across its Paterson and Murchison copper portfolio. The funding supports the phased restart of the Nifty Copper Complex in Western Australia (Figure 1), where first cathode production is targeted for mid-2026, while also advancing studies for future expansion and satellite feed opportunities.

Noel Ong
3 days ago6 min read


Pivotal Metals – Multiple Gold & Copper Targets Defined at Lorraine – A District-Scale Cu-Ni-Au Exploration Leverage - Decent Looking Targets - Cautious DYOR Required.
Samso is drawn to Pivotal Metals because the Company is applying systematic, district-scale geophysics to expand known high-grade mineral systems rather than relying on isolated drill targets. The combination of historic production, bonanza-grade gold intersections, and newly defined geophysical anomalies creates a technically coherent exploration narrative that is supported by infrastructure and jurisdictional advantages in Québec.

Noel Ong
5 days ago7 min read


Samso News: Firebird Metals – LMR Cathode Equipment Commissioned – A Vertically Integrated Manganese story that is Driven with A Battery Materials Optionality.
Firebird Metals Limited (ASX: FRB) has completed the installation and commissioning of its proprietary cathode active materials (CAM) equipment at its wholly owned China pilot plant, marking a key step in advancing lithium-manganese-rich (LMR) cathode development. The milestone supports Firebird’s vertically integrated ore-to-cathode strategy, with initial LMR CAM production scheduled to commence in February 2026 and customer sampling planned for the second half of 2026.

Noel Ong
5 days ago6 min read


Samso News: NeuroScientific Biopharmaceuticals Limited – StemSmart™ Delivers Clinical Responses in Fistulising Crohn’s Disease – Time for understaing when to take your position.
Samso is drawn to NeuroScientific because the Company is transitioning from early-stage development into real-world clinical validation. The Special Access Program outcomes represent a tangible inflection point, where clinical efficacy, regulatory engagement, and manufacturing readiness begin to converge around a scalable therapeutic platform.

Noel Ong
5 days ago8 min read


Samso News: ReNerve Limited — A Peripheral Nerve Injury Story – Too Early To Take A Position?
ReNerve Limited has secured market registration approval in Malaysia for its NervAlign® Nerve Cuff, marking another regulatory milestone in the Company’s Asia-Pacific expansion strategy. The approval adds to existing clearances in Hong Kong and Thailand and follows a positive assessment of ReNerve’s clinical evaluation data. With an established US commercial base and a growing portfolio of nerve repair and tissue products.

Noel Ong
Jan 217 min read


Samso News: Western Yilgarn Limited— Secures Expanded Land Access at West Julimar - Growing a Scalable Bauxite Resource Base.
Western Yilgarn NL (ASX: WYX) has executed new land access agreements over Zones 100 and 200 at its West Julimar Bauxite Project in the Darling Range of Western Australia (Figure 1). These agreements provide access to extensive areas of lateritic bauxite immediately adjoining and between the Company’s existing JORC-compliant Mineral Resource areas, opening a clear pathway for potential resource expansion.

Noel Ong
Jan 216 min read


Samso News: Terra Critical Minerals — Closes Acquisition of the High-Grade True American Tungsten Project in Nevada, USA - A US Focused Tungsten Optionality.
Terra Critical Minerals Limited (ASX: T92) has closed the acquisition of the 100%-owned True American Tungsten Project, located in central Nevada, USA. The transaction marks Terra’s formal entry into the U.S. tungsten space, securing a historically high-grade project within a recognised mining jurisdiction and positioning the Company for on-the-ground work programs in 2026.

Noel Ong
Jan 216 min read
bottom of page
